Article: Genmab licenses MIF from Cytokine PharmaSciences.(macrophage migration inhibitory factor)(Brief article)

Danish biotechnology company Genmab AS says that it has licensed rights to a macrophage migration inhibitory factor (MIF) receptor from Cytokine PharmaSciences of the USA. MIF is a pro-inflammatory cytokine that is known to activate T cells and macrophages. Genmab said that it ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!